Navigation Links
OPKO Management and Israel's Minister of Science Open TASE Trading in Honor of OPKO'S Dual-Listing on TASE

TEL-AVIV, Israel, August 21, 2013 /PRNewswire/ --

This morning the Tel Aviv Stock Exchange (TASE) held an opening bell ceremony honoring the dual listing of the OPKO Health, Inc., which was attended by  Israel's Minister of Science, Technology and Space and senior management from OPKO, PROLOR Biotech and TASE.


     (Photo: )

The Minister of Science, Technology and Space, Yaacov Peri, stated the OPKO's dual listing on TASE constitutes another stage in the process of establishing Israel as an international leader in the bio-pharma industries. The listing of multinational concern on the Tel Aviv Stock Exchange should not be taken for granted, particularly during these times of regional and economic turmoil. The dual listing underscores Israel's strength. "I hope that OPKO's listing is a harbinger for other international multinational companies."

Dr. Phillip Frost, OPKO's Chairman and CEO stated the "We at OPKO believe that we will profit from PROLOR's talent and experience. The merger between OPKO and PROLOR is a prime example of what cooperation between Israel and the U.S. and other countries can yield. PROLOR contains talented professionals, which to my mind constitute the heart and soul of Israel and the Israeli mind. What Israel needs today is 10 companies like Teva; one is not enough. I am certain that PROLOR, together with OPKO, will become a success story like Teva in the near future, and it is interesting to see that there are other companies here harboring the same potential. The Israeli mind does not cease to amaze and is definitely worth study and investment."

Ester Levanon, TASE CEO, said that "This is a special day for TASE. OPKO's dual listing is recognition of the special position the biomed sector holds at the Tel Aviv Stock Exchange, and it constitutes a vote of confidence in Israel's capital market. In the past years TASE has managed to turn into a hub for biomed companies. At the end of 2005 only 12 biomed firms were listed on TASE. Today 59 companies are listed, 7 of which are dual listed. This sector is larger than what is currently found on European exchanges."

In the picture (right to left): Shai Novik, CEO PROLOR; Dr. Phillip Frost, Chairman and CEO, OPKO; Ester Levanon, CEO, TASE; Yaacov Peri, Minister of Science, Technology and Space; Dr. Ron Malka, Interim Chairman of the Board, TASE.

Credit for photograph: Moshe Shay with compliments

    Orna Goren
    Deputy Manager
    Marketing & Communications Unit
    The Tel-Aviv Stock Exchange
    T: +972(3)5677405
    F: +972(3)5105376
    M: +972(52)3400843
    A: 54 Ahad Ha'am St., Tel-Aviv 65202, Israel

SOURCE Tel Aviv Stock Exchange Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
2. Sangamo BioSciences Announces Presentation At The 2013 Wedbush Life Sciences Management Access Conference
3. Clinovo Presents Its Paper ‘Cloud for Clinical Trials’ at Society for Clinical Data Management (SCDM) Conference 2013
4. Pain Management Therapeutics Market is Expected to Decline to USD 29.47 Billion Globally by 2018: Transparency Market Research
5. LIMS 24/7 and Ayrris: Big-Data Lab Management for Production-Scale NGS
6. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
7. Molecular Biomarkers for Cancer Detection and Management
8. Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
9. VG Life Sciences, Inc. Announces Management Changes
10. Elsevier Supports Russias ROSATOM Knowledge Management Program
11. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
Post Your Comments:
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):